BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33477264)

  • 21. Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.
    Tomaszewski N; He X; Solomon V; Lee M; Mack WJ; Quinn JF; Braskie MN; Yassine HN
    J Alzheimers Dis; 2020; 74(3):975-990. PubMed ID: 32116250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial.
    Nakao K; Noguchi T; Asaumi Y; Morita Y; Kanaya T; Fujino M; Hosoda H; Yoneda S; Kawakami S; Nagai T; Nishihira K; Nakashima T; Kumasaka R; Arakawa T; Otsuka F; Nakanishi M; Kataoka Y; Tahara Y; Goto Y; Yamamoto H; Hamasaki T; Yasuda S
    Trials; 2018 Jan; 19(1):12. PubMed ID: 29310688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma eicosapentaenoic acid is negatively associated with all-cause mortality among men and women in a population-based prospective study.
    Miura K; Hughes MCB; Ungerer JP; Green AC
    Nutr Res; 2016 Nov; 36(11):1202-1209. PubMed ID: 27865614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyunsaturated Fatty Acid Impact on Clinical Outcomes in Acute Coronary Syndrome Patients With Dyslipidemia: Subanalysis of HIJ-PROPER.
    Arashi H; Yamaguchi J; Kawada-Watanabe E; Koyanagi R; Sekiguchi H; Mori F; Haruta S; Ishii Y; Murasaki S; Suzuki K; Yamauchi T; Ogawa H; Hagiwara N
    J Am Heart Assoc; 2019 Aug; 8(16):e012953. PubMed ID: 31390907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma polyunsaturated fatty acid profile and delta-5 desaturase activity are altered in patients with type 2 diabetes.
    Imamura S; Morioka T; Yamazaki Y; Numaguchi R; Urata H; Motoyama K; Mori K; Fukumoto S; Shoji T; Emoto M; Inaba M
    Metabolism; 2014 Nov; 63(11):1432-8. PubMed ID: 25173718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ratio of eicosapentaenoic acid to arachidonic acid is a critical risk factor for acute coronary syndrome in middle-aged older patients as well as younger adult patients.
    Serikawa T; Miura S; Okabe M; Hongo H; Tokutome M; Yoshikawa T; Takesue K; Adachi S; Osaka K; Matsukawa R; Yanagi D; Nozoe M; Kozai T; Hironaga K; Saku K; Yamamoto Y
    J Cardiol; 2014 Jan; 63(1):35-40. PubMed ID: 23993904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between Polyunsaturated Fatty Acid and Reactive Oxygen Species Production of Neutrophils in the General Population.
    Suzuki N; Sawada K; Takahashi I; Matsuda M; Fukui S; Tokuyasu H; Shimizu H; Yokoyama J; Akaike A; Nakaji S
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33105547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effects of Lipid-Lowering Therapy on Serum Eicosapentaenoic Acid to Arachidonic Acid Ratio: An HIJ-PROPER Sub-Analysis.
    Arashi H; Yamaguchi J; Kawada-Watanabe E; Otsuki H; Sekiguchi H; Ogawa H; Hagiwara N
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):548-555. PubMed ID: 32567339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LC-MS/MS analysis of plasma polyunsaturated fatty acids in type 2 diabetic patients after insulin analog initiation therapy.
    Aslan M; Özcan F; Aslan I; Yücel G
    Lipids Health Dis; 2013 Nov; 12():169. PubMed ID: 24195588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study.
    Ninomiya T; Nagata M; Hata J; Hirakawa Y; Ozawa M; Yoshida D; Ohara T; Kishimoto H; Mukai N; Fukuhara M; Kitazono T; Kiyohara Y
    Atherosclerosis; 2013 Dec; 231(2):261-7. PubMed ID: 24267237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls.
    Block RC; Harris WS; Reid KJ; Sands SA; Spertus JA
    Atherosclerosis; 2008 Apr; 197(2):821-8. PubMed ID: 17875307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered Serum n-6 Polyunsaturated Fatty Acid Profile and Risks of Mortality and Cardiovascular Events in a Cohort of Hemodialysis Patients.
    Kuwamura Y; Shoji T; Okute Y; Yamazaki Y; Motoyama K; Morioka T; Mori K; Fukumoto S; Tsujimoto Y; Shioi A; Emoto M; Inaba M
    J Ren Nutr; 2018 Jan; 28(1):54-63. PubMed ID: 29089279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age Stratification and Impact of Eicosapentaenoic Acid and Docosahexaenoic Acid to Arachidonic Acid Ratios in Ischemic Stroke Patients.
    Ueno Y; Tanaka R; Yamashiro K; Miyamoto N; Hira K; Kurita N; Sakurai M; Urabe T; Shimada K; Miyazaki T; Daida H; Hattori N
    J Atheroscler Thromb; 2018 Jul; 25(7):593-605. PubMed ID: 29199200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Clinical Significance of Low Serum Arachidonic Acid in Sepsis Patients with Hypoalbuminemia.
    Yamaguchi J; Kinoshita K; Ihara S; Furukawa M; Sakurai A
    Intern Med; 2018 Jul; 57(13):1833-1840. PubMed ID: 29491308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin and omega-3 fatty acid status interact in the prevention of cardiovascular diseases in Framingham Heart Study.
    Block RC; Shearer GC; Holub A; Tu XM; Mousa S; Brenna JT; Harris WS; Tintle N
    Prostaglandins Leukot Essent Fatty Acids; 2021 Jun; 169():102283. PubMed ID: 33964664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analytic review of polyunsaturated fatty acid compositions in dementia.
    Lin PY; Chiu CC; Huang SY; Su KP
    J Clin Psychiatry; 2012 Sep; 73(9):1245-54. PubMed ID: 22938939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between the ratio of serum n-3 to n-6 polyunsaturated fatty acids and acute coronary syndrome in non-obese patients with coronary risk factor: a multicenter cross-sectional study.
    Nishizaki Y; Shimada K; Tani S; Ogawa T; Ando J; Takahashi M; Yamamoto M; Shinozaki T; Miyazaki T; Miyauchi K; Nagao K; Hirayama A; Yoshimura M; Komuro I; Nagai R; Daida H
    BMC Cardiovasc Disord; 2020 Apr; 20(1):160. PubMed ID: 32252654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Fatty Acid Therapy in Addition to Strong Statin on Coronary Plaques in Acute Coronary Syndrome: An Optical Coherence Tomography Study.
    Kita Y; Watanabe M; Kamon D; Ueda T; Soeda T; Okayama S; Ishigami K; Kawata H; Horii M; Inoue F; Doi N; Okura H; Uemura S; Saito Y
    J Am Heart Assoc; 2020 Aug; 9(16):e015593. PubMed ID: 32805184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of serum n-6 polyunsaturated fatty acids in the development of acute coronary syndromes.
    Inoue N; Morikawa S; Murohara T
    Nagoya J Med Sci; 2023 Aug; 85(3):592-601. PubMed ID: 37829479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between Preoperative Long-Chain Polyunsaturated Fatty Acids and Oxidative Stress Immediately after Total Knee Arthroplasty: A Pilot Study.
    Kubo Y; Ikeya M; Sugiyama S; Takachu R; Tanaka M; Sugiura T; Kobori K; Kobori M
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34205251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.